Patent ‘shenanigans’ keep drug costs high
By law, generics makers have to follow the same protocol that the branded companies use. A patent throws up barriers to compliance. The Federal Trade Commission may be considering whether Jazz deliberately thwarted competition, the company said in a regulatory filing. Jazz spokeswoman Kristin …